Report

src

Global Pharmacovigilance Market by Product Type (Preclinical, Phase I, Phase II, Phase III, Phase IV) and by End-users/Application (In-house & Contract outsourcing) Global Market Share, Forecast Data, In-Depth Analysis, and Detailed Overview, and Forecast, 2015 - 2027

 Report Code
 Category
 Published Date
 Pages
 Format
MNR-1332
Pharmaceuticals
13 May 2020
217
PDF
Customization
  • We provide customized solutions to cater to your specific requirement services any region, product, or any specific market segment.

The report on the global pharmacovigilance market analyzes complete scenario i.e., existing as well as future visions of pharmacovigilance market. It includes detailed overview of pharmacovigilance market along with market pictures. Additionally, report has included complete data of the various segments in the global pharmacovigilance market followed by its applications, end users and region wide segmentation. Moreover, report has highlights of global key players present in this market. Top global players are analyzed completely along with their financials, technological innovations, key developments, apart from future strategies, SWOT analysis, acquisitions & mergers, and market footprint.

Global pharmacovigilance market report offers in-depth insights, revenue details, and other vital information regarding the global pharmacovigilance market, and the various trends, drivers, restraints, opportunities, and threats in the target market till year 2027. Hence, it covers the impact of these drivers and restraints on demand for this market during the forecast period. The report also includes PEST analysis, Porter’s Five Forces analysis, and opportunity map analysis for in-depth understanding of the market.

It provides historical data along with future forecast as well as detailed analysis of market on a global, regional and country level. Important market data of this market is projected in the form of form of tables, graphics, and pictures. On a regional basis, the market is categorized into five regions that include North America, Europe, Asia Pacific, Latin America, and Middle & East Africa. It analyzes complete scenario of each and every region along with highest share holder of pharmacovigilance market.

Market Segmentation:
Segmentation by Type Preclinical
Phase I
Phase II
Phase III
Phase IV
Segmentation by Application In-house
Contract outsourcing
Market, By Regions North America (the United States, Canada, and Mexico)
Europe (Germany, UK, France, Italy, and Russia, etc.)
Asia-Pacific (China, Japan, ASEAN, India, and Korea)
The Middle East and Africa (UAE, Egypt, South Africa, Saudi Arabia)
South America (Brazil, Chile, Peru, and Argentina)

In addition, pharmacovigilance market report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period.

Report also provides factors that are contributing to and influencing the expansion of the global pharmacovigilance market. It projects the market assessment for the predicted time. Along with all these report includes the manufacturing process along with shipment, price, revenue, gross profit, potential, interview records, business distribution, etc. This enables users to get complete scenario of competitive analysis of the market.

Pivotal Fundamentals of the Global Pharmacovigilance Market Report:
  • Holistic in-depth detailed analysis, regarding the parent market.
  • Detailed information about the current R&D activities performed by each pharmacovigilance market player.
  • Region-wise and country-wise breakdown of the pharmacovigilance market to get the revenue, and growth lookout in these areas.
  • Key factors which are influencing the consumption pattern of consumers across various regions and countries.
  • Historical and future progress of the global pharmacovigilance market.
  • Year-on-year growth of the global pharmacovigilance market in terms of value and volume.
Conclusion:
At last report covers a short outline of the dealers, distributors, and suppliers. Additionally, it provides sales channel, analysis findings and results. It spots some new entrants within the market. The study thus, suggests a brand new proposition to embellish pharmacovigilance market and nurture business as it explains current global market as well as future market.

Chapter 1 Pharmacovigilance Market Overview
1.1 Product Overview and Scope of Pharmacovigilance

Chapter 2 Executive Summary 
2.1 Drivers for Pharmacovigilance Market: 
2.2 Restrain for Pharmacovigilance Market:
2.3 Opportunity for Pharmacovigilance Market: 
2.4 Global Pharmacovigilance market, 2015 - 2027
2.5 Global Pharmacovigilance market, by Region, 2015 - 2027
2.6 Global Pharmacovigilance market, by Type, 2015 - 2027
2.7 Global Pharmacovigilance market, by Application, 2015 - 2027

Chapter 3 Pharmacovigilance Segment by Types (Product Category) 
3.1 Global Pharmacovigilance Revenue (USD Million) and Growth Rate (%) Comparison by Types (2015-2020) 
3.2 Global Pharmacovigilance Revenue Market Share (%) by Types in 2019
3.3 Preclinical
3.4 Phase I
3.5 Phase II
3.6 Phase III
3.7 Phase IV

Chapter 4 Global Pharmacovigilance Segment by Application 
4.1 Global Pharmacovigilance Revenue (USD Million) Comparison by Application (2015-2027) 
4.2 In-house
4.3 Contract outsourcing

Chapter 5 Global Pharmacovigilance Market by Regions (2015-2027) 
5.1 Global Pharmacovigilance Market Size and Growth Rate (%) Comparison by Regions (2015-2027) 
5.2 North America Pharmacovigilance Status and Prospect (2015-2027) 
5.3 Europe Pharmacovigilance Status and Prospect (2015-2027) 2
5.4 Asia Pacific Pharmacovigilance Status and Prospect (2015-2027) 3
5.5 South America Pharmacovigilance Status and Prospect (2015-2027) 
5.6 Middle East & Africa Pharmacovigilance Status and Prospect (2015-2027) 
5.7 Global Pharmacovigilance Market Size (2015-2027) 
            5.7.1 Global Pharmacovigilance Revenue Status and Outlook (2015-2027) 
            
Chapter 6 Global Pharmacovigilance Market Competition by Manufacturers
6.1 Global Pharmacovigilance Revenue and Share by Manufacturers (2015-2019) 

Chapter 7 Company (Top Players) Profiles and Key Data
7.1 Accenture
            7.1.1 Company Basic Information and Sales Area
            7.1.2 Business Segment/ Overview
            7.1.3 Investment in Research and Development
            7.1.4 Pharmacovigilance Product Types Specification
            7.1.5 Key Developments
            7.1.6 Business Strategy
7.2 Boehringer Ingelheim
            7.2.1 Company Basic Information and Sales Area
            7.2.2 Business Segment/ Overview
            7.2.3 Investment in Research and Development
            7.2.4 Pharmacovigilance Product Types Specification
            7.2.5 Business Strategy
7.3 Bristol-Myers Squibb
            7.3.1 Company Basic Information, and Sales Area
            7.3.2 Business Segment/ Overview
            7.3.3 Pharmacovigilance Product Types Specification
            7.3.4 Key Developments
            7.3.5 Business Strategy
7.4 Clinquest Group
            7.4.1 Company Basic Information and Sales Area. 
            7.4.2 Business Segment/ Overview
            7.4.3 Pharmacovigilance Product Types Specification
            7.4.4 Business Strategy
7.5 Cognizant
            7.5.1 Company Basic Information and Sales Area. 
            7.5.2 Business Segment/ Overview
            7.5.3 Pharmacovigilance Product Types Specification
            7.5.4 Business Strategy
7.6 Ecron Acunova 
            7.6.1 Company Basic Information, and Sales Area
            7.6.2 Business Segment/ Overview
            7.6.3 Pharmacovigilance Product Types Specification
            7.6.4 Business Strategy
7.7 F. Hoffmann-La Roche
            7.7.1 Company Basic Information, and Sales Area
            7.7.2 Business Segment/ Overview
            7.7.3 Investment in Research and Development
            7.7.4 Pharmacovigilance Product Types Specification
            7.7.5 Key Developments
            7.7.6 Business Strategy
7.8 GlaxoSmithKline
            7.8.1 Company Basic Information and Sales Area. 
            7.8.2 Business Segment/ Overview
            7.8.3 Pharmacovigilance Product Types Specification
            7.8.4 Business Strategy
7.9 HCL Technologies
            7.9.1 Company Basic Information, and Sales Area
            7.9.2 Business Segment/ Overview
            7.9.3 Pharmacovigilance Product Types Specification
            7.9.4 Business Strategy
7.10 IBM Corporation
            7.10.1 Company Basic Information, and Sales Area
            7.10.2 Business Segment/ Overview
            7.10.3 Pharmacovigilance Product Types Specification
            7.10.4 Business Strategy
            
Chapter 8 Global Pharmacovigilance Revenue by Regions (2015-2020) 
8.1 Global Pharmacovigilance Revenue and Market Share (%) by Regions (2015-2020) 

Chapter 9 Global Pharmacovigilance Revenue by Types
9.1 Global Pharmacovigilance Revenue and Market Share (%) by Types (2015-2020) 

Chapter 10 Global Pharmacovigilance Market Analysis by Application
10.1 Global Pharmacovigilance Revenue (USD Million) and Market Share (%) by Application (2015-2020) 
10.2 Global Pharmacovigilance Revenue Growth Rate by Application (2015-2020) 

Chapter 11 North America Pharmacovigilance Market Development Status and Outlook
11.1 North America Pharmacovigilance Market Size (2015-2020) 
            11.1.1 North America Pharmacovigilance Market Size by Type (USD Million) (2015-2020) 
11.2 North America Pharmacovigilance Market Size (2015-2020) 
            11.2.1 North America Pharmacovigilance Market Size by Application (USD Million) (2015-2020) 
11.3 U.S
            11.3.1 U.S. Pharmacovigilance market, by Type, 2015 - 2027
            11.3.2 U.S. Pharmacovigilance market, by Application, 2015 – 2027
11.4 Canada
            11.4.1 Canada Pharmacovigilance market, by Type, 2015 - 2027
            11.4.2 Canada Pharmacovigilance market, by Application, 2015 – 2027
11.5 Mexico
            11.5.1 Mexico Pharmacovigilance market, by Type, 2015 - 2027
            11.5.2 Mexico Pharmacovigilance market, by Application, 2015 – 2027
            
Chapter 12 Europe Pharmacovigilance Market Development Status and Outlook
12.1 Europe Pharmacovigilance Market Size (2015-2020) 
            12.1.1 Europe Pharmacovigilance Market Size by Type (USD Million) (2015-2020) 
12.2 Europe Pharmacovigilance Market Size (2015-2020) 
            12.2.1 Europe Pharmacovigilance Market Size by Application (USD Million) (2015-2020) 
12.3 U.K.
            12.3.1 U.K. Pharmacovigilance market, by Type, 2015 - 2027
            12.3.2 U.K. Pharmacovigilance market, by Application, 2015 – 2027
12.4 Germany
            12.4.1 Germany Pharmacovigilance market, by Type, 2015 - 2027
            12.4.2 Germany Pharmacovigilance market, by Application, 2015 – 2027
12.5 France
            12.5.1 France Pharmacovigilance market, by Type, 2015 – 2027
            12.5.2 France Pharmacovigilance market, by Application, 2015 – 2027
12.6 Italy
            12.6.1 Italy Pharmacovigilance market, by Type, 2015 – 2027
            12.6.2 Italy Pharmacovigilance market, by Application, 2015 – 2027
12.7 Spain
            12.7.1 Spain Pharmacovigilance market, by Type, 2015 – 2027
            12.7.2 Spain Pharmacovigilance market, by Application, 2015 – 2027
12.8 Rest of Europe
            12.8.1 Rest of Europe Pharmacovigilance market, by Type, 2015 – 2027
            12.8.2 Rest of Europe Pharmacovigilance market, by Application, 2015 – 2027
            
Chapter 13 Asia Pacific Pharmacovigilance Market Development Status and Outlook
13.1 Asia Pacific Pharmacovigilance Market Size (2015-2020) 
            13.1.1 Asia Pacific Pharmacovigilance Market Size by Type (USD Million) (2015-2020) 
13.2 Asia Pacific Pharmacovigilance Market Size (2015-2020) 
            13.2.1 Asia Pacific Pharmacovigilance Market Size by Application (USD Million) (2015-2020) 
13.3 China
            13.3.1 China Pharmacovigilance market, by Type, 2015 – 2027
            13.3.2 China Pharmacovigilance market, by Application, 2015 – 2027
13.4 Japan
            13.4.1 Japan Pharmacovigilance market, by Type, 2015 – 2027
            13.4.2 Japan Pharmacovigilance market, by Application, 2015 – 2027
13.5 India
            13.5.1 India Pharmacovigilance market, by Type, 2015 – 2027
            13.5.2 India Pharmacovigilance market, by Application, 2015 – 2027
13.6 Southeast Asia
            13.6.1 Southeast Asia Pharmacovigilance market, by Type, 2015 – 2027
            13.6.2 Southeast Asia Pharmacovigilance market, by Application, 2015 – 2027
            
Chapter 14 South America Pharmacovigilance Market Development Status and Outlook
14.1 South America Pharmacovigilance Market Size (2015-2020) 
            14.1.1 South America Pharmacovigilance Market Size by Type (USD Million) (2015-2020) 
14.2 South America Pharmacovigilance Market Size (2015-2020) 
            14.2.1 South America Pharmacovigilance Market Size by Application (USD Million) (2015-2020) 
14.3 Brazil
            14.3.1 Brazil Pharmacovigilance market, by Type, 2015 – 2027
            14.3.2 Brazil Pharmacovigilance market, by Application, 2015 – 2027 
14.4 Argentina
            14.4.1 Argentina Pharmacovigilance market, by Type, 2015 – 2027
            14.4.2 Argentina Pharmacovigilance market, by Application, 2015 – 2027 
14.5 Colombia
            14.5.1 Colombia Pharmacovigilance market, by Type, 2015 – 2027
            14.5.2 Colombia Pharmacovigilance market, by Application, 2015 – 2027
14.6 Rest of South America
            14.6.1 Colombia Pharmacovigilance market, by Type, 2015 – 2027
            14.6.2 Colombia Pharmacovigilance market, by Application, 2015 – 2027
            
Chapter 15 Middle East & Africa Pharmacovigilance Market Development Status and Outlook
15.1 Middle East & Africa Pharmacovigilance Market Size (2015-2020) 
            15.1.1 Middle East & Africa Pharmacovigilance Market Size by Type (USD Million) (2015-2020) 
15.2 Middle East & Africa Pharmacovigilance Market Size (2015-2020) 
            15.2.1 Middle East & Africa Pharmacovigilance Market Size by Application (2015-2020) 
15.3 UAE
            15.3.1 UAE Pharmacovigilance market, by Type, 2015 – 2027
            15.3.2 UAE Pharmacovigilance market, by Application, 2015 – 2027
15.4 South Africa
            15.4.1 South Africa Pharmacovigilance market, by Type, 2015 – 2027
            15.4.2 South Africa Pharmacovigilance market, by Application, 2015 – 2027
15.5 Egypt
            15.5.1 Egypt Pharmacovigilance market, by Type, 2015 – 2027
            15.5.2 Egypt Pharmacovigilance market, by Application, 2015 – 2027
15.6 Rest of MEA
            15.6.1 Rest of MEA Pharmacovigilance market, by Type, 2015 – 2027
            15.6.2 Rest of MEA Pharmacovigilance market, by Application, 2015 – 2027
            
Chapter 16 Pharmacovigilance Manufacturing Cost Analysis
16.1 Proportion of Manufacturing Cost Structure
            16.1.1 Raw Materials
            16.1.2 Labor Cost
            16.1.3 USA Labor Cost Analysis
            16.1.4 EU Labor Costs Analysis
            16.1.5 China Labor Costs Analysis
            16.1.6 Manufacturing Expenses
            
Chapter 17 Marketing Strategy Analysis, Distributors/ Traders
17.1 Marketing Channel
            17.1.1 Direct Marketing
            17.1.2 Indirect Marketing
            17.1.3 Marketing Channel Development Trend
17.2 Market Positioning
            17.2.1 Pricing Strategy
            
Chapter 18 Global Pharmacovigilance Market Forecast (2020-2027) 
18.1 Global Pharmacovigilance Revenue Forecast (2020-2027) 
            18.1.1 Global Pharmacovigilance Revenue (USD Million) and Growth Rate (%) Forecast (2020-2027) 
18.2 Global Pharmacovigilance Revenue (USD Million) Forecast by Regions (2020-2027) 
            18.2.1 North America Pharmacovigilance Revenue (USD Million) Forecast (2020-2027) 
            18.2.2 Europe Pharmacovigilance Revenue (USD Million) Forecast (2020-2027) 
            18.2.3 Asia Pacific Pharmacovigilance and Revenue (USD Million) Forecast (2020-2027) 
            18.2.4 South America Pharmacovigilance and Revenue (USD Million) Forecast (2020-2027) 
            18.2.5 Middle East & Africa Pharmacovigilance and Revenue (USD Million) Forecast (2020-2027) 
18.3 Global Pharmacovigilance Revenue Forecast by Type (2020-2027) 
18.4 Global Pharmacovigilance Revenue (USD Million) Forecast by Application (2020-2027) 

Chapter 19 North America Pharmacovigilance Market Development Status and Outlook
19.1 North America Pharmacovigilance Market Size (2020-2027) 
            19.1.1 North America Pharmacovigilance Market Size by Type (USD Million) (2020-2027) 
19.2 North America Pharmacovigilance Market Size (2020-2027) 
            19.2.1 North America Pharmacovigilance Market Size by Application (USD Million) (2020-2027) 
19.3 U.S.
            19.3.1 U.S. Pharmacovigilance market, by Type, 2020 – 2027
            19.3.2 U.S. Pharmacovigilance market, by Application, 2020 – 2027
19.4 Canada
            19.4.1 Canada Pharmacovigilance market, by Type, 2020 – 2027
            19.4.2 Canada Pharmacovigilance market, by Application, 2020 – 2027
19.5 Mexico
            19.5.1 Mexico Pharmacovigilance market, by Type, 2020 – 2027
            19.5.2 Mexico Pharmacovigilance market, by Application, 2020 – 2027
            
Chapter 20 Europe Pharmacovigilance Market Development Status and Outlook
20.1 Europe Pharmacovigilance Market Size (2020-2027) 
            20.1.1 Europe Pharmacovigilance Market Size by Type (USD Million) (2020-2027) 
20.2 Europe Pharmacovigilance Market Size (2020-2027) 
            20.2.1 Europe Pharmacovigilance Market Size by Application (USD Million) (2020-2027) 
20.3 U.K.
            20.3.1 U.K. Pharmacovigilance market, by Type, 2020 – 2027
            20.3.2 U.K. Pharmacovigilance market, by Application, 2020 – 2027
20.4 Germany
            20.4.1 Germany Pharmacovigilance market, by Type, 2020 – 2027
            20.4.2 Germany Pharmacovigilance market, by Application, 2020 – 2027
20.5 France
            20.5.1 France Pharmacovigilance market, by Type, 2020 – 2027
            20.5.2 France Pharmacovigilance market, by Application, 2020 – 2027
20.6 Italy
            20.6.1 France Pharmacovigilance market, by Type, 2020 – 2027
            20.6.2 France Pharmacovigilance market, by Application, 2020 – 2027
20.7 Spain
            20.7.1 France Pharmacovigilance market, by Type, 2020 – 2027
            20.7.2 France Pharmacovigilance market, by Application, 2020 – 2027
20.8 Rest of Europe
            20.8.1 France Pharmacovigilance market, by Type, 2020 – 2027
            20.8.2 France Pharmacovigilance market, by Application, 2020 – 2027
            
Chapter 21 Asia Pacific Pharmacovigilance Market Development Status and Outlook
21.1 Asia Pacific Pharmacovigilance Market Size (2020-2027) 
            21.1.1 Asia Pacific Pharmacovigilance Market Size by Type (USD Million) (2020-2027) 
21.2 Asia Pacific Pharmacovigilance Market Size (2020-2027) 
            21.2.1 Asia Pacific Pharmacovigilance Market Size by Application (USD Million) (2020-2027) 
21.3 China
            21.3.1 China Pharmacovigilance market, by Type, 2020 – 2027
            21.3.2 China Pharmacovigilance market, by Application, 2020 – 2027
21.4 Japan
            21.4.1 Japan Pharmacovigilance market, by Type, 2020 – 2027
            21.4.2 Japan Pharmacovigilance market, by Application, 2020 – 2027
21.5 India
            21.5.1 India Pharmacovigilance market, by Type, 2020 – 2027
            21.5.2 India Pharmacovigilance market, by Application, 2020 – 2027
21.6 Southeast Asia
            21.6.1 Southeast Asia Pharmacovigilance market, by Type, 2020 – 2027
            21.6.2 Southeast Asia Pharmacovigilance market, by Application, 2020 – 2027
            
Chapter 22 South America Pharmacovigilance Market Development Status and Outlook
22.1 South America Pharmacovigilance Market Size (2020-2027) 
            22.1.1 South America Pharmacovigilance Market Size by Type (USD Million) (2020-2027) 
22.2 South America Pharmacovigilance Market Size (2020-2027) 
            22.2.1 South America Pharmacovigilance Market Size by Application (USD Million) (2020-2027) 
22.3 Brazil
            22.3.1 Brazil Pharmacovigilance market, by Type, 2020 – 2027
            22.3.2 Brazil Pharmacovigilance market, by Application, 2020 – 2027 
22.4 Argentina
            22.4.1 Argentina Pharmacovigilance market, by Type, 2020 – 2027
            22.4.2 Argentina Pharmacovigilance market, by Application, 2020 – 2027 
22.5 Colombia
            22.5.1 Colombia Pharmacovigilance market, by Type, 2020 – 2027
            22.5.2 Colombia Pharmacovigilance market, by Application, 2020 – 2027
22.6 Rest of South America
            22.6.1 Colombia Pharmacovigilance market, by Type, 2020 – 2027
            22.6.2 Colombia Pharmacovigilance market, by Application, 2020 – 2027
            
Chapter 23 Middle East & Africa Pharmacovigilance Market Development Status and Outlook
23.1 Middle East & Africa Pharmacovigilance Market Size (2020-2027) 
            23.1.1 Middle East & Africa Pharmacovigilance Market Size by Type (USD Million) (2020-2027) 
23.2 Middle East & Africa Pharmacovigilance Market Size (2020-2027) 
            23.2.1 Middle East & Africa Pharmacovigilance Market Size by Application (USD Million) (2020-2027) 
23.3 UAE
            23.3.1 UAE Pharmacovigilance market, by Type, 2020 – 2027
            23.3.2 UAE Pharmacovigilance market, by Application, 2020 – 2027
23.4 South Africa
            23.4.1 South Africa Pharmacovigilance market, by Type, 2020 – 2027
            23.4.2 South Africa Pharmacovigilance market, by Application, 2020 – 2027
23.5 Egypt
            23.5.1 Egypt Pharmacovigilance market, by Type, 2020 – 2027
            23.5.2 Egypt Pharmacovigilance market, by Application, 2020 – 2027
24.6 Rest of MEA
            24.6.1 Rest of MEA Pharmacovigilance market, by Type, 2020 – 2027
            24.6.2 Rest of MEA Pharmacovigilance market, by Application, 2020 – 2027
            
Chapter 25 Research Findings and Conclusion
 

No Methodology

Global Pharmacovigilance Market Trends:
The global pharmacovigilance is estimated to be worth USD 4,870 million in 2019 and is projected to reach USD 13,110 million by 2027, at a CAGR of 13.2% from 2020 to 2027.

Pharmacovigilance is the science and activities involved in the detection, understanding, assessment and prevention of adverse drug effects or other drug-related problems. Hence pharmacovigilance refers to the process of preventing and monitoring adverse drug reactions. However adverse drug reaction (ADR) is an undesirable and unwanted effect of a medication that occurs during its clinical use. Moreover rising number of Adverse drug reaction is a major concern of the pharmacovigilance field and will contribute to significant increase in the demand for clinical data management services over the forecast period.

The surging prevalence of chronic diseases is a key driving factor of the pharmacovigilance market. However rising demand for continuous pharmacovigilance for effective surveillance of Adverse drug reaction  will render several growth opportunities for the market expansion. Moreover, increased risk of data security that can be misused by pharmacovigilance personnel may hamper market demand over the coming years.

Global Pharmacovigilance Market, By Type:
Based on Clinical Trial Phase, the market is categorized into Preclinical, Phase I, Phase II, Phase III, and Phase IV. On the basis of Clinical Trial Phase, Phase IV accounted for largest share of total revenue generated due to the  extensive post-marketing surveillance of pharmaceuticals and increasing adverse drug  reaction incidences. Additionally, it is a significant stage of clinical trials where the adverse drug reactions which were unsuspected can be detected. Ascribed to this, the data that is collected during this stage is if utmost importance. Thus all these factors are propelling the segmental growth.

Global Pharmacovigilance, By Application:
Based on service provider, the market is categorized into In-house & Contract outsourcing. The demand of Global Pharmacovigilance Market is highest from Contract outsourcing, due to the shift in focus of pharmaceutical companies toward outsourcing services to reduce operational cost. In addition to this, it helps in increasing the efficiency and cost-effectiveness by relieving the manufacturing companies of the pressure. Thus all these factors will led to propelling the segmental growth

Global Pharmacovigilance market, By Region:
Report covers the region wise analysis, global pharmacovigilance market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among all, Asia Pacific leads the global pharmacovigilance market share followed by North America & Europe. While the Asia Pacific leads the global pharmacovigilance market due to the availability of low-cost labor and rising number of outsourcing companies in this region. However strict regulations for reporting adverse drug reactions coupled with large number of companies offering pharmacovigilance outsourcing services across the region will foster the market growth. In addition, increasing funding for clinical trials will further spur the regional market outlook over the analysis period.

Major Market Players:
The research study includes profiles of leading companies operating in the global pharmacovigilance market. Key players profiled in the report include: Accenture, Boehringer Ingelheim, Bristol-Myers Squibb, Clinquest Group, Cognizant, Ecron Acunova, F. Hoffmann-La Roche, GlaxoSmithKline, HCL Technologies & IBM Corporation.

Global Pharmacovigilance Market Report Scope:
Report Parameters Details of Parameter
Market Size 2015-2027
Based Year 2019
Forecast Period Covered 2020-2027
Units for value USD (Million)
Covered Segments Product Type, Applications, Geographic Regions
Product Type Preclinical, Phase I, Phase II, Phase III, Phase IV
Applications In-house & Contract outsourcing
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Covered Accenture, Boehringer Ingelheim, Bristol-Myers Squibb, Clinquest Group, Cognizant, Ecron Acunova, F. Hoffmann-La Roche, GlaxoSmithKline, HCL Technologies & IBM Corporation

The report analyzes all the factors which are impacting on the market and on that basis describes the drivers, restraints, and opportunities for the growth of the global pharmacovigilance market. Similarly, report provides the all the segmentations along with the qualitative analysis.

Global Pharmacovigilance Market: Product analysis
  • Preclinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
Global Pharmacovigilance Market: Application analysis
  • In-house
  • Contract outsourcing
Market, by regions:
In addition, pharmacovigilance report sorted and categorized the information and data according to the major geographical regions which are expected to impact on the industry in forecast period. Following are the regions we covered in this report:
  • North America (U.S., Canada, Mexico)
  • Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)
  • Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)
  • Latin America (Brazil, Rest of L.A.)
  • Middle East and Africa (Turkey, GCC, Rest of Middle East)
 
 
 

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase